Additionally, the pH of the solution induced

Additionally, the pH of the solution induced VX-809 purchase important effects on the optical fluorescent behaviour of the ZnS-chitosan bioconjugates which was assigned to the ‘trap states’ emissions involving the defect states of the QDs. Hence, new cadmium-free biocompatible colloids based on ZnS QDs capped by chitosan were successfully developed

exhibiting luminescent activity that may be tuned by adjusting the pH with great potential for use in biomedical and eco-friendly applications. Acknowledgements The authors acknowledge the financial support from CAPES, FAPEMIG and CNPq. The authors express their gratitude to the staff from the Microscopy Centre/UFMG for the TEM analysis. Electronic supplementary material Additional Estrogen antagonist file 1: Figure S1: Infrared spectra of chitosan (pH = 4.0). Inset: vibrational region: 1,750 to 1,400 cm-1. (DOC 326 KB) Additional file 2: Figure S2: FTIR spectra of CHI (a) and CHI-ZnS (b) at pH = 5.0 ± 0.2. Vibrational regions: 1,750 to 1,475 cm-1 (left) and 1,250 to 950 cm-1 (right). (DOC

312 KB) Additional file 3: Figure S3: FTIR spectra of CHI (a) and CHI-ZnS (b) in the range of 3,700 to 3,050 cm-1 at pH 6.0 ± 0.2 (A), pH = 5.0 ± 0.2 (B) and pH = 4.0 ± 0.2 (C). (DOC 448 KB) Additional file 4: Figure S4: Potentiometric titration curve of 75 mg of chitosan dissolved in 0.1 mol.L-1 HCl solution (a) and its derivative (b). (DOC 144 KB) References 1. Feynman RP: There’s plenty of room at the bottom. Eng Sci 1960, 23:22–36. 2. Toumey CP: Reading Feynman into nanotechnology. Techné: Res Philos Technol 2008, 12:133–168. 3. Emerich DF: Nanomedicine – prospective

therapeutic and diagnostic applications. Anidulafungin (LY303366) Expert Opin Biol Ther 2005, 5:1–5.CrossRef 4. Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, Cullough J: The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine 2013, 9:1–14. 5. Tan WB, Huang N, Zhang Y: Ultrafine biocompatible chitosan nanoparticles encapsulating multi-coloured quantum dots for bioapplications. J Colloid Interface Sci 2007, 310:464–470.CrossRef 6. Costa-Júnior ES, Barbosa-Stancioli EF, Mansur AAP, Vasconcelos WL, Mansur HS: Preparation and characterization of chitosan/poly(vinyl alcohol) chemically crosslinked blends for biomedical applications. Carbohydr Polym 2009, 76:472–481.CrossRef 7. Dash M, Chiellini F, Ottenbrite RM, Chiellini E: Chitosan—a versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci 2011, 36:981–1014.CrossRef 8. Rinaudo M: Chitin and chitosan: properties and applications. Prog Polym Sci 2006, 31:603–632.CrossRef 9. Xia W, Liu P, Zhang J, Chen J: Biological activities of chitosan and chitooligosaccharides. Food Hydrocoll 2011, 25:170–179.CrossRef 10. Zhang J, Xia W, Liu P, Cheng Q, Tahi T, Gu W, Li B: Chitosan modification and pharmaceutical/biomedical applications. Mar Drugs 2010, 8:1962–1987.CrossRef 11.

Comments are closed.